GDUFA Facility List Lags Last Year, May Be Trailed By Higher Fees
Executive Summary
Fewer generic drug facilities have self-identified with the agency than the same time in 2013, perhaps due to their capital situation.
You may also be interested in...
Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree
Small business owners say the GDUFA facility and other fees are too expensive, especially while waiting for ANDAs to be approved, but any small business waiver is unlikely until GDUFA II.
GDUFA Facility Self-Identification Is Key Element For Speedy ANDA Approval
Industry officials say sponsors have to police all the facilities they use and reference to make sure ANDAs are not held up or exclusivity lost.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.